Qunying Mao

1.1k total citations
23 papers, 659 citations indexed

About

Qunying Mao is a scholar working on Infectious Diseases, Animal Science and Zoology and Immunology. According to data from OpenAlex, Qunying Mao has authored 23 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 7 papers in Animal Science and Zoology and 6 papers in Immunology. Recurrent topics in Qunying Mao's work include SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (9 papers) and Animal Virus Infections Studies (7 papers). Qunying Mao is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (9 papers) and Animal Virus Infections Studies (7 papers). Qunying Mao collaborates with scholars based in China, India and United States. Qunying Mao's co-authors include Zhenglun Liang, Miao Xu, Qian He, Lianlian Bian, Fan Gao, Jialu Zhang, Junzhi Wang, Qian Wang, Xing Wu and Changgui Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Qunying Mao

21 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qunying Mao China 11 500 146 124 88 78 23 659
Justin DaSilva United States 5 509 1.0× 121 0.8× 101 0.8× 58 0.7× 90 1.2× 6 598
Maegan L. Sheehan United States 6 663 1.3× 154 1.1× 100 0.8× 100 1.1× 75 1.0× 9 727
Angelique Hœlzemer Germany 6 620 1.2× 151 1.0× 92 0.7× 144 1.6× 62 0.8× 7 734
Dennis Schaefer-Babajew United States 4 564 1.1× 108 0.7× 108 0.9× 70 0.8× 97 1.2× 5 639
Bethany Girard United States 9 590 1.2× 130 0.9× 120 1.0× 111 1.3× 55 0.7× 24 694
Onosereme Ofoman United States 3 768 1.5× 192 1.3× 105 0.8× 128 1.5× 73 0.9× 3 821
Cristhian Berrios United States 3 769 1.5× 192 1.3× 105 0.8× 130 1.5× 73 0.9× 4 823
Charles Kevin Tiu Singapore 3 765 1.5× 108 0.7× 56 0.5× 76 0.9× 63 0.8× 4 811
Anne Cossmann Germany 12 795 1.6× 167 1.1× 76 0.6× 88 1.0× 62 0.8× 27 912
Michael T. Boswell South Africa 8 679 1.4× 184 1.3× 51 0.4× 71 0.8× 51 0.7× 11 751

Countries citing papers authored by Qunying Mao

Since Specialization
Citations

This map shows the geographic impact of Qunying Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qunying Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qunying Mao more than expected).

Fields of papers citing papers by Qunying Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qunying Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qunying Mao. The network helps show where Qunying Mao may publish in the future.

Co-authorship network of co-authors of Qunying Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Qunying Mao. A scholar is included among the top collaborators of Qunying Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qunying Mao. Qunying Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Qian, Jing Zhang, Lifang Song, et al.. (2025). Early transcriptional divergence in mRNA vaccines reveals molecular correlates of humoral efficacy. Biochemical and Biophysical Research Communications. 776. 152199–152199.
3.
Zhang, Yi, Jialu Zhang, Dongmei Li, et al.. (2024). A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model. Viruses. 16(3). 484–484. 1 indexed citations
4.
Mao, Qunying, Jianyang Liu, Xuanxuan Zhang, et al.. (2023). Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard. Frontiers in Immunology. 14. 1107639–1107639. 4 indexed citations
5.
Gao, Fan, Chaoqiang An, Lianlian Bian, et al.. (2022). Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine. Vaccine. 40(14). 2233–2239. 4 indexed citations
6.
Liu, Jianyang, Qunying Mao, Xing Wu, et al.. (2022). Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines. Frontiers in Immunology. 13. 814365–814365. 10 indexed citations
7.
Han, Lu, Chaoqiang An, Dong Liu, et al.. (2022). Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content. Viruses. 15(1). 62–62. 5 indexed citations
8.
Bian, Lianlian, Yu Bai, Fan Gao, et al.. (2022). Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice. Virology Journal. 19(1). 86–86. 3 indexed citations
9.
Wang, Qian, Qian He, Qunying Mao, et al.. (2022). Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV. Emerging Microbes & Infections. 11(1). 1145–1153. 11 indexed citations
10.
Liu, Dong, Chaoqiang An, Yu Bai, et al.. (2022). A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine. Viruses. 14(9). 1854–1854. 3 indexed citations
11.
Bai, Yu, Qian Wang, Mingchen Liu, et al.. (2022). The next major emergent infectious disease: reflections on vaccine emergency development strategies. Expert Review of Vaccines. 21(4). 471–481. 12 indexed citations
12.
Bai, Yu, Qian He, Shuaiyao Lu, et al.. (2022). B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman Primates. Microbiology Spectrum. 10(5). e0226322–e0226322. 6 indexed citations
13.
Wang, Qian, Xing Wu, Qunying Mao, et al.. (2022). How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review. Expert Review of Anti-infective Therapy. 20(8). 1119–1127. 3 indexed citations
14.
Bian, Lianlian, Fan Gao, Jialu Zhang, et al.. (2021). Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies. Expert Review of Vaccines. 20(4). 365–373. 122 indexed citations
15.
He, Qian, Qunying Mao, Jialu Zhang, et al.. (2021). COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations. Frontiers in Immunology. 12. 669339–669339. 74 indexed citations
16.
Bian, Lianlian, Fan Gao, Qian Wang, et al.. (2021). Impact of the Delta variant on vaccine efficacy and response strategies. Expert Review of Vaccines. 20(10). 1201–1209. 160 indexed citations
17.
Mao, Qunying, Miao Xu, Qian He, et al.. (2021). COVID-19 vaccines: progress and understanding on quality control and evaluation. Signal Transduction and Targeted Therapy. 6(1). 199–199. 22 indexed citations
18.
He, Qian, Qunying Mao, Chaoqiang An, et al.. (2021). Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates. Emerging Microbes & Infections. 10(1). 629–637. 100 indexed citations
19.
Chuang, Wen‐Yu, Hui-Yun Cheng, Qunying Mao, et al.. (2016). Combined Anti‐CD154/CTLA4Ig Costimulation Blockade‐Based Therapy Induces Donor‐Specific Tolerance to Vascularized Osteomyocutaneous Allografts. American Journal of Transplantation. 16(7). 2030–2041. 31 indexed citations
20.
Mao, Qunying, Shulong Feng, Wei Liu, & John W. Y. Lit. (2006). Bistability-Mapping for$L$-Band Dual-Wavelength Erbium-Doped Fiber Laser by Using Fiber Loop Mirror With Polarization Controller. IEEE Photonics Technology Letters. 18(18). 1973–1975. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin DaSilva Breakdown of academic impact, for papers by Maegan L. Sheehan Breakdown of academic impact, for papers by Angelique Hœlzemer Breakdown of academic impact, for papers by Dennis Schaefer-Babajew Breakdown of academic impact, for papers by Bethany Girard Breakdown of academic impact, for papers by Onosereme Ofoman Breakdown of academic impact, for papers by Cristhian Berrios Breakdown of academic impact, for papers by Charles Kevin Tiu Breakdown of academic impact, for papers by Anne Cossmann Breakdown of academic impact, for papers by Michael T. Boswell
Rankless by CCL
2026